- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Degenerative myopia.
Displaying page 1 of 1.
EudraCT Number: 2018-001286-16 | Sponsor Protocol Number: APP-study | Start Date*: 2018-11-05 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Low-dose Atropine for the Prevention of Childhood Myopia Progression in Danish Children (APP-study) | |||||||||||||
Medical condition: Childhood myopia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006785-15 | Sponsor Protocol Number: IOBA-02-2007 | Start Date*: 2008-03-10 | ||||||||||||||||
Sponsor Name:IOBA - Instituto Universitario de Oftalmobiología Aplicada | ||||||||||||||||||
Full Title: EFFICACY AND SECURITY OF INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANES ASSOCIATED TO HIGH MYOPIA EVALUACIÓN DE LA EFICACIA Y SEGURIDAD DE LA INYECCIÓN INTRAVÍTREA D... | ||||||||||||||||||
Medical condition: Choroidal neovascular membrane in high myopia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003976-42 | Sponsor Protocol Number: OT_101_001 | Start Date*: Information not available in EudraCT |
Sponsor Name:Ocumension (Hong Kong) Limited | ||
Full Title: A phase III, randomized, double-masked, placebo controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine 0.01%) in treating the progression of myopia in pediatri... | ||
Medical condition: myopia | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) SK (Trial now transitioned) IE (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021662-30 | Sponsor Protocol Number: CRFB002F2301 | Start Date*: 2010-11-05 | |||||||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||||||||||||
Full Title: A 12 month, phase III, randomized, double-masked, multi-center, active-controlled study to evaluate the efficacy and safety of two different dosing regimens of 0.5 mg ranibizumab vs. verteporfin PD... | |||||||||||||||||||||||
Medical condition: visual impairment due to choroidal neovascularization secondary to pathologic myopia | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: PT (Completed) LV (Completed) HU (Completed) LT (Completed) FR (Completed) ES (Completed) IT (Completed) AT (Completed) SK (Completed) DE (Completed) GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
